By inhibiting the TGF-β/Smad signaling axis and EMT, two major factors implicated in scleroderma, nimbolide administration induced regression of inflammation-driven fibrosis in a murine model of bleomycin-induced scleroderma. The gene discussed is TGFB1; the disease is scleroderma.